GDF15 propeptide is a novel and useful biomarker for bone metastases in prostate cancer
-
- Yamamichi Gaku
- Dept. Urology, Osaka Univ. Grad. Sch. Med.
-
- Kato Taigo
- Dept. Urology, Osaka Univ. Grad. Sch. Med.
-
- Myoba Shohei
- Biosci Div, Tosoh Corp.
-
- Oka Toshiki
- Dept. Urology, Osaka Univ. Grad. Sch. Med.
-
- Okuda Yohei
- Dept. Urology, Osaka Univ. Grad. Sch. Med.
-
- Uemura Toshihiro
- Dept. Urology, Osaka Univ. Grad. Sch. Med.
-
- Yamamoto Akinaru
- Dept. Urology, Osaka Univ. Grad. Sch. Med.
-
- Tomiyama Eisuke
- Dept. Urology, Osaka Univ. Grad. Sch. Med.
-
- Ishizuya Yu
- Dept. Urology, Osaka Univ. Grad. Sch. Med.
-
- Yamamoto Yoshiyuk
- Dept. Urology, Osaka Univ. Grad. Sch. Med.
-
- Hatano Koji
- Dept. Urology, Osaka Univ. Grad. Sch. Med.
-
- Kawashima Atsunari
- Dept. Urology, Osaka Univ. Grad. Sch. Med.
-
- Uemura Motohide
- Dept. Urology, Osaka Univ. Grad. Sch. Med. Dept. Urology, Iwase Gen. Hosp. Dept. Urology, Fukushima Med Univ.
-
- Nonomura Norio
- Dept. Urology, Osaka Univ. Grad. Sch. Med.
Bibliographic Information
- Other Title
-
- 前立腺癌における GDF15 プロペプチドの骨転移診断マーカーとしての有用性
Search this article
Journal
-
- Japan Journal of Molecular Tumor Marker Research
-
Japan Journal of Molecular Tumor Marker Research 38 (0), 42-43, 2022
Japanese Society for Molecular Tumor Marker Research
- Tweet
Details 詳細情報について
-
- CRID
- 1390013098760557056
-
- ISSN
- 24338575
-
- Text Lang
- ja
-
- Data Source
-
- JaLC